Ophthalmology Doctors in Spokane Valley, WA Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Dr. Mark A Kontos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16010 E Indiana Ave, Spokane Valley, WA 99216 Phone: 509-928-8040    Fax: 509-928-0784

Dr. Robert W Hander, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 12120 E Mission Ave, #2, Spokane Valley, WA 99206 Phone: 509-927-0700    Fax: 509-927-7537

Dr. Loren Stanley Seery, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16818 E Desmet Ct, Spokane Valley, WA 99216 Phone: 509-456-5380    Fax: 509-456-5381

Dr. Christopher W Sturbaum, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16010 E Indiana Ave, Spokane Valley, WA 99216 Phone: 509-928-8040    Fax: 509-928-0784

Mr. Jason Albert Croskrey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16010 E Indiana Ave, Spokane Valley, WA 99216 Phone: 509-928-8040    Fax: 509-928-0784

Donald U Stone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16201 E Indiana Ave Ste 5000, Spokane Valley, WA 99216 Phone: 509-924-7271    Fax: 509-928-7802

Dr. Jonathan G Haymore, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16201 E Indiana Ave Ste 5000, Spokane Valley, WA 99216 Phone: 509-456-0107    Fax: 509-747-2635

News Archive

CMS proposed rule that would increase payments to acute care hospitals

The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that would increase payments to acute care hospitals for inpatient services in fiscal year 2005

Nymox second-quarter net loss increases to $1.75 million

Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.

HMS fourth quarter revenues increase 31.4% to $87.2 million

HMS Holdings Corp. today announced financial results for its fourth quarter and full year ended December 31, 2010.

How stable are mRNA vaccines under continuous movement?

Researchers tested reconstituted COVID-19 mRNA vaccines under different movement conditions and found that a moderate continuous movement does not damage the mRNA, which may increase the possibility of transporting reconstituted vaccine over a few hundred kilometers.

Nuvo Research intends to proceed with its proposed share consolidation

Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.

Read more Medical News

› Verified 9 days ago